Most people shouldn’t bother taking daily low-dose aspirin to reduce their risk of a first heart attack or stroke, the nation’s leading panel of preventive medicine experts announced Tuesday. The U.S. Preventive Services Task Force (USPSTF) issued a draft recommendation that essentially backs off its previous advice urging many folks to consider taking low-dose aspirin…  read on >  read on >

Patients who undergo surgery for certain types of cancer may have better short-term survival if they receive a particular anti-nausea drug, a preliminary study suggests. Among more than 74,000 patients who had cancer surgery, researchers found that those who received the drug — called dexamethasone — were less likely to die in the next 90…  read on >  read on >

TUESDAY, Oct. 12, 2021 (American Heart Association News) — The pandemic has highlighted societal inequities that leave historically disenfranchised communities more at risk for COVID-19 exposure. But recent studies suggest the disparities more severely impact Hispanic people who only speak Spanish, especially when it comes to unemployment and food insecurity. “This is about structural racism…  read on >  read on >

Merck & Co. announced Monday that it had submitted an application with the U.S. Food and Drug Administration for emergency use approval of the first antiviral pill targeted to COVID-19. Experts say authorization of molnupiravir, at this time only for use inhigh-risk Americans, could be a major advance in the struggle against COVID-19 because a…  read on >  read on >

Golf carts aren’t just for golfing anymore: They also abound in retirement communities, on farms, and at sporting and other events. But the downside of that newfound popularity may be that an increasing number of children and adolescents are injured from the carts each year, a new study suggests. A research team from the Children’s…  read on >  read on >